Research Article
Pretreatment Serum Uric Acid as an Efficient Predictor of Prognosis in Men with Laryngeal Squamous Cell Cancer: A Retrospective Cohort Study
Table 1
Baseline demographics and lifestyle characteristics of laryngeal squamous cell cancer patients.
| Covariates | Number of patients/mean |
| No. of individuals | 814 | Age at diagnosis (years), mean, range | 60.66, 27-89 | >60 | 399 | ≥60 | 415 | Body mass index (kg/m2), mean, range | 22.94, 16.72-28.43 | Male (%) | 100% | Death events | 191 | Duration of follow-up (months), median, range | 72, 3-116 | Smoking history (yes/no) | 570/244 | Drinking history (yes/no) | 309/505 | Hypertension (yes/no) | 229/585 | Median recurrence (months), range | 23, 1-95 | T stage | | T1 | 195 | T2 | 328 | T3 | 239 | T4 | 52 | N stage | | N0 | 722 | N1 | 31 | N2 | 52 | N3 | 9 | TNM stage | | I | 195 | II | 302 | III | 216 | IV | 101 | Tumour size (cm), mean, range | 1.80, 0-6.5 | Tumour size (≤2 cm/>2 cm) | 511/303 | Neck dissection (yes/no) | 145/669 | Operation therapy | | Total laryngectomy | 326 | Partial laryngectomy | 488 | Tumour subsite | | Supraglottic | 179 | Subglottic | 11 | Glottic | 624 |
|
|